Other Information
−Removed: No directors or officers adopted , modified or terminated a Rule 10b5-1 trading arrangement during the fiscal quarter ended June 30, 2026.
+Added: No directors or officers adopted , modified or terminated a Rule 10b5-1 trading arrangement during the fiscal quarter ended September 30, 2026.
Exhibit Number Description
+Added: Amendment No.
+Added: 1 to Amended and Restated Credit Agreement, dated as of July 24, 2026, among Balchem, the Foreign Borrower, the Domestic Guarantors, the Agents, and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed July 27, 2026).
+Added: Omnibus Reaffirmation and Amendment Agreement, dated as of July 24, 2026, among Balchem, the Domestic Guarantors and JPMorgan Chase Bank, N.A.
+Added: (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on July 27, 2026).
+Added: Balchem Corporation Insider Trading Policy (filed herewith).
Certification of Chief Executive Officer pursuant to Rule 13a-14(a).
18 unchanged sentences
Chief Financial Officer
−Removed: July 31, 2026
+Added: October 23, 2026
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.